Safety and efficacy of celecoxib, a specific COX-2 inhibitor, in patients with rheumatoid arthritis.

被引：0
|
作者：
Geis, GS [1 ]
Hubbard, R [1 ]
Callison, D [1 ]
Yu, S [1 ]
Zhao, W [1 ]
机构：
[1] GD Searle & Co, Skokie, IL 60077 USA
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1990
引用
收藏
页码：S364 / S364
页数：1
相关论文
共 50 条
  • [21] COX-2 inhibitors in rheumatoid arthritis
    Sundy J.S.
    Current Rheumatology Reports, 2001, 3 (1) : 86 - 91
  • [22] Clinical pharmacology of celecoxib, a COX-2 selective inhibitor
    Antoniou, Katerina
    Malamas, Michael
    Drosos, Alexandros A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (11) : 1719 - 1732
  • [23] COX-2 and its inhibitor Celecoxib in corneal neovascularization
    Dong, Yuan
    Zhang, Ming-Chang
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2008, 1 (01) : 13 - 17
  • [24] Discovery of the COX-2 selective inhibitor celecoxib.
    Talley, JJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U56 - U56
  • [25] Efficacy and Safety of the Selective Cyclooxygenase-2 Inhibitor Celecoxib in the Treatment of Rheumatoid Arthritis and Osteoarthritis in Japan
    Sakamoto, Choitsu
    Soen, Satoshi
    DIGESTION, 2011, 83 (1-2) : 108 - 123
  • [26] META-ANALYSIS OF THE EFFECTIVENESS AND SAFETY OF THE USE OF CELECOXIB IN THE MANAGEMENT OF CHRONIC PAIN VS OTHER COX-2 IN PATIENTS WITH OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS
    Vargas-Valencia, J. J.
    Granados-Soto, V
    Galindo-Suarez, R. M.
    Mould-Quevedo, J.
    VALUE IN HEALTH, 2011, 14 (07) : A561 - A561
  • [27] Characterization of the clinically effective dose range of MK-0663, a COX-2 selective inhibitor, in the treatment of rheumatoid arthritis.
    Curtis, SP
    Maldonado-Cocco, J
    Lozada, B
    Gallacher, A
    Ng, Y
    Ng, J
    Ehrich, E
    Gertz, BJ
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S226 - S226
  • [28] Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH
    Wang, Jiping
    Cho, Nancy L.
    Zauber, Ann G.
    Hsu, Meier
    Dawson, Dawn
    Srivastava, Amitabh
    Mitchell-Richards, Kisha A.
    Markowitz, Sanford D.
    Bertagnolli, Monica M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 728 - 736
  • [29] Prescribing consequences of COX-2 inhibitor withdrawal for veterans administration rheumatoid arthritis patients.
    Skamra, Carly
    Reddy, Virginia
    Lee, Yvonne
    Zeringue, Angelique
    Brasington, Richard
    Eisen, Seth
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S110 - S110
  • [30] Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo
    Bensen, WG
    Zhao, SZ
    Burke, TA
    Zabinski, RA
    Makuch, RW
    Maurath, CJ
    Agrawal, NM
    Geis, GS
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (08) : 1876 - 1883
12345